A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria Participants
- Conditions
- Interventions
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 40
- Registration Number
- NCT04444466
- Locations
- ๐ง๐ฌ
Up0086 001, Sofia, Bulgaria
A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
- Conditions
- Interventions
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 508
- Registration Number
- NCT04436640
- Locations
- ๐ง๐ฌ
As0014 40005, Sofia, Bulgaria
๐ฏ๐ตAs0014 20031, Sapporo, Japan
๐ต๐ฑAs0014 40044, Poznan, Poland
A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2020-05-19
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 95
- Registration Number
- NCT04393298
- Locations
- ๐บ๐ธ
Onc001 50414, Los Angeles, California, United States
๐ฌ๐งOnc001 40304, Manchester, United Kingdom
๐ฌ๐งOnc001 40305, Glasgow, United Kingdom
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Zampilimab in Adult Kidney Transplant Recipients With Chronic Allograft Injury
- First Posted Date
- 2020-04-06
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 3
- Registration Number
- NCT04335578
- Locations
- ๐ง๐ช
Cai001 101, Leuven, Belgium
๐ฌ๐งCai001 501, London, United Kingdom
๐ช๐ธCai001 302, Hospitalet de Llobregat, Spain
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- First Posted Date
- 2020-03-04
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 321
- Registration Number
- NCT04294667
- Locations
- ๐บ๐ธ
Sl0043 50418, Colleyville, Texas, United States
๐ง๐ฌSl0043 40380, Sofia, Bulgaria
๐บ๐ธSl0043 50257, La Jolla, California, United States
A Study to Test the Blood Concentration of 4 Padsevonil Product Variants and the Effect of Food on Padsevonil
- First Posted Date
- 2020-02-25
- Last Posted Date
- 2020-06-22
- Lead Sponsor
- UCB Biopharma SRL
- Registration Number
- NCT04283136
A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study Participants
- First Posted Date
- 2020-02-05
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 71
- Registration Number
- NCT04255862
- Locations
- ๐ฉ๐ช
Up0068 001, Berlin, Germany
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 505
- Registration Number
- NCT04242446
- Locations
- ๐บ๐ธ
Hs0003 50270, Seattle, Washington, United States
๐บ๐ธHs0003 50149, San Antonio, Texas, United States
๐บ๐ธHs0003 50175, Phoenix, Arizona, United States
A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 509
- Registration Number
- NCT04242498
- Locations
- ๐บ๐ธ
Hs0004 50184, Pembroke Pines, Florida, United States
๐บ๐ธHs0004 50223, Savannah, Georgia, United States
๐บ๐ธHs0004 50199, Miami, Florida, United States
A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
- Conditions
- Interventions
- First Posted Date
- 2020-01-13
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 30
- Registration Number
- NCT04224688
- Locations
- ๐ท๐บ
Tp0006 20053, Saint Petersburg, Russian Federation
๐บ๐ฆTp0006 20061, Cherkasy, Ukraine
๐บ๐ฆTp0006 20064, Kyiv, Ukraine